| Financial Year |
March 31 2023 |
| Monetary Funds |
380,265,478.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
249,221,116.69 |
| Advances to Suppliers |
14,155,143.89 |
| Other Receivables |
1,688,612.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
188,414,253.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,621,263.62 |
| Total Current Assets |
955,334,346.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,784,568.16 |
| Investment Properties |
-- |
| Fixed Assetes |
668,961,240.58 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
100,641,171.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,054,873.14 |
| Deferred Income Tax Assets |
10,098,422.92 |
| Other Non-Current Assets |
35,855,717.06 |
| Sub-Total of Non-Current Assets |
903,395,993.55 |
| Total Assets |
1,858,730,339.73 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
115,420,000.00 |
| Accounts Payable |
179,610,833.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,694,441.89 |
| Taxes Payable |
10,315,210.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
915,347.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
319,141,832.39 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,177,200.00 |
| Deferred Income Tax Liabilities |
19,825,623.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
64,671,935.09 |
| Total Liabilities |
383,813,767.48 |
| Paid-In Capital(Or Share Stock) |
307,445,000.00 |
| Capital Surplus |
696,790,930.31 |
| Surplus Reserve |
119,082,007.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
354,151,373.24 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,474,916,572.25 |
| Owner's Equity（Stockholder's Equity） |
1,474,916,572.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,858,730,339.73 |
